Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion type Assertion NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_head.
- NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion wasGeneratedBy ECO_0000203 NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_provenance.
- NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion wasDerivedFrom befree-20150227 NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_provenance.
- NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion SIO_000772 18942640 NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_provenance.
- NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion evidence source_evidence_literature NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_provenance.
- NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410364.RAQ7-Vln72HUBV-d4oMOuXqmhzoj3YDmPas3RU2EYF4rc130_provenance.